What is your guideline for perioperative management in RA patients on biologics undergoing spinal fusion surgery?

Topics: Rheumatology • Rheumatoid Arthritis

Do you hold the biologic for more than 2 weeks post-op? It seems the spine surgeons want a much more cautious approach. Do you follow the ACR/AAHKS guidelines on this?

Related Questions

How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?

Can you use leflunomide and rituximab in a patient with both multiple sclerosis and rheumatoid arthritis?

Do you consider Anti-carbamylated protein antibodies (anti-CarP) as having any significance in evaluation of patients if RF and ACPA negative and clinically no active synovitis yet widespread arthralgias and generalized osteoarthritis?

How do you manage a patient with severe RA or SLE that worsens after stopping immunosuppressants due to having chronic foot ulceration?

What is your approach for an RA patient with lung cancer who is starting immunotherapy?

Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?

Can JAK inhibitors for established rheumatoid arthritis be continued when starting an immune checkpoint inhibitor?

How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?

How would you approach treating a patient with Rheumatoid arthritis/Psoriatic arthritis and alcoholic cirrhosis?

How do you approach managing nausea and GI side effects when initiating methotrexate?